Minister of State for Well being Anupriya Patel was responding to a query on whether or not India's first malaria vaccine, R21/Matrix-M, has been co-developed by the College of Oxford and the Serum Institute of India and if the vaccine has obtained regulatory approval to be used within the nation.
“The matter to be used of Malaria vaccine in context of India has been reviewed in a duly constituted knowledgeable committee which really helpful that India doesn't fall throughout the standards for adopting Malaria vaccines because the vaccines are used for reasonable to excessive transmission settings with a threat of Malaria deaths in kids,” she stated in a written reply.